| Authors . | Year . | Participant groups and sample sizes . | State of disease activity for IBD participants . | |
|---|---|---|---|---|
| Active | Remitted/Inactive | |||
| Crohn’s disease | ||||
| Huang et al. | 2024 | CD active (62), CD remitted (59), HC (91) | Yes | Yes |
| Sun et al. | 2024 | CD with anxiety or depression (33), CD without anxiety or depression (31), HC (29) | No | Yes |
| Thapaliya et al. | 2023 | CD (25), HC (25) | Yes | No |
| Chen et al. | 2023 | CD with pain (24), CD without pain (24), HC (28) | No | Yes |
| Agostini et al. | 2023 | CD active (19), CD remitted (14), HC (18) | Yes | Yes |
| Li et al. | 2022 | CD (20), HC (22) | Yes | aNA |
| Qiu et al. | 2022 | CD (22), HC (22) | Yes | aYes |
| Zhang et al. | 2022 | CD (45), HC (40) | No | Yes |
| Huang et al. | 2022 | CD active (58), CD inactive (57), HC (91) | Yes | Yes |
| Kong et al. | 2022 | CD (34), HC (20) | Yes | Yes |
| Li et al. | 2021 | CD (15), HC (26) | No | Yes |
| Kornelsen et al. | 2020 | CD (35), HC (21) | Yes | Yes |
| Fan et al. | 2020 | CD (42), HC (35) | No | Yes |
| Hou et al. | 2019 | CD (18), HC (18) | No | Yes |
| Bao at al. | 2018 | CD (60), HC (40) | No | Yes |
| Liu et al. | 2018 | CD (43), HC (37) | No | Yes |
| Thomann et al. | 2017 | CD (15), HC (14) | No | Yes |
| Bao et al. | 2016 | CD with pain (25), CD without pain (25), HC (32) | No | Yes |
| Ulcerative colitis | ||||
| Wang et al. | 2022 | UC, IBS, and HC, n = 74 each) | aYes | Yes |
| Kornelsen et al. | 2021 | UC (76), HC (74) | aYes | Yes |
| Fan et al. | 2019 | UC (41), HC (42) | Yes | No |
| IBD combined | ||||
| Wang et al. | 2023 | IBD (combined; subtype not specified: 37), HC (32) | Yes | No |
| Deng et al. | 2023 | IBD (combined; subtype not specified: 27), HC (29) | No | Yes |
| Goodyear et al. | 2023 | IBD (26 CD | 9 UC), HC (32) | Yes | Yes |
| Kornelsen et al. | 2022 | IBD (CD 35, UC 76), HC (74) | Yes | Yes |
| Prub et al. | 2022 | IBD patients with chronic abdominal pain (32; CD 26 | UC 6), HC (32) | aYes | Yes |
| Thomann et al. | 2021 | IBD patients (31; CD 19 | UC 12), HC (13) | No | Yes |
| Authors . | Year . | Participant groups and sample sizes . | State of disease activity for IBD participants . | |
|---|---|---|---|---|
| Active | Remitted/Inactive | |||
| Crohn’s disease | ||||
| Huang et al. | 2024 | CD active (62), CD remitted (59), HC (91) | Yes | Yes |
| Sun et al. | 2024 | CD with anxiety or depression (33), CD without anxiety or depression (31), HC (29) | No | Yes |
| Thapaliya et al. | 2023 | CD (25), HC (25) | Yes | No |
| Chen et al. | 2023 | CD with pain (24), CD without pain (24), HC (28) | No | Yes |
| Agostini et al. | 2023 | CD active (19), CD remitted (14), HC (18) | Yes | Yes |
| Li et al. | 2022 | CD (20), HC (22) | Yes | aNA |
| Qiu et al. | 2022 | CD (22), HC (22) | Yes | aYes |
| Zhang et al. | 2022 | CD (45), HC (40) | No | Yes |
| Huang et al. | 2022 | CD active (58), CD inactive (57), HC (91) | Yes | Yes |
| Kong et al. | 2022 | CD (34), HC (20) | Yes | Yes |
| Li et al. | 2021 | CD (15), HC (26) | No | Yes |
| Kornelsen et al. | 2020 | CD (35), HC (21) | Yes | Yes |
| Fan et al. | 2020 | CD (42), HC (35) | No | Yes |
| Hou et al. | 2019 | CD (18), HC (18) | No | Yes |
| Bao at al. | 2018 | CD (60), HC (40) | No | Yes |
| Liu et al. | 2018 | CD (43), HC (37) | No | Yes |
| Thomann et al. | 2017 | CD (15), HC (14) | No | Yes |
| Bao et al. | 2016 | CD with pain (25), CD without pain (25), HC (32) | No | Yes |
| Ulcerative colitis | ||||
| Wang et al. | 2022 | UC, IBS, and HC, n = 74 each) | aYes | Yes |
| Kornelsen et al. | 2021 | UC (76), HC (74) | aYes | Yes |
| Fan et al. | 2019 | UC (41), HC (42) | Yes | No |
| IBD combined | ||||
| Wang et al. | 2023 | IBD (combined; subtype not specified: 37), HC (32) | Yes | No |
| Deng et al. | 2023 | IBD (combined; subtype not specified: 27), HC (29) | No | Yes |
| Goodyear et al. | 2023 | IBD (26 CD | 9 UC), HC (32) | Yes | Yes |
| Kornelsen et al. | 2022 | IBD (CD 35, UC 76), HC (74) | Yes | Yes |
| Prub et al. | 2022 | IBD patients with chronic abdominal pain (32; CD 26 | UC 6), HC (32) | aYes | Yes |
| Thomann et al. | 2021 | IBD patients (31; CD 19 | UC 12), HC (13) | No | Yes |
Studies comparing resting-state pre–post intervention are not listed above.
aAssumed inclusion in a sample based on the presentation of means and standard deviations of continuous variables for assessing disease activity.
Abbreviations: CD = Crohn’s disease; HC = healthy controls; UC = ulcerative colitis.
| Authors . | Year . | Participant groups and sample sizes . | State of disease activity for IBD participants . | |
|---|---|---|---|---|
| Active | Remitted/Inactive | |||
| Crohn’s disease | ||||
| Huang et al. | 2024 | CD active (62), CD remitted (59), HC (91) | Yes | Yes |
| Sun et al. | 2024 | CD with anxiety or depression (33), CD without anxiety or depression (31), HC (29) | No | Yes |
| Thapaliya et al. | 2023 | CD (25), HC (25) | Yes | No |
| Chen et al. | 2023 | CD with pain (24), CD without pain (24), HC (28) | No | Yes |
| Agostini et al. | 2023 | CD active (19), CD remitted (14), HC (18) | Yes | Yes |
| Li et al. | 2022 | CD (20), HC (22) | Yes | aNA |
| Qiu et al. | 2022 | CD (22), HC (22) | Yes | aYes |
| Zhang et al. | 2022 | CD (45), HC (40) | No | Yes |
| Huang et al. | 2022 | CD active (58), CD inactive (57), HC (91) | Yes | Yes |
| Kong et al. | 2022 | CD (34), HC (20) | Yes | Yes |
| Li et al. | 2021 | CD (15), HC (26) | No | Yes |
| Kornelsen et al. | 2020 | CD (35), HC (21) | Yes | Yes |
| Fan et al. | 2020 | CD (42), HC (35) | No | Yes |
| Hou et al. | 2019 | CD (18), HC (18) | No | Yes |
| Bao at al. | 2018 | CD (60), HC (40) | No | Yes |
| Liu et al. | 2018 | CD (43), HC (37) | No | Yes |
| Thomann et al. | 2017 | CD (15), HC (14) | No | Yes |
| Bao et al. | 2016 | CD with pain (25), CD without pain (25), HC (32) | No | Yes |
| Ulcerative colitis | ||||
| Wang et al. | 2022 | UC, IBS, and HC, n = 74 each) | aYes | Yes |
| Kornelsen et al. | 2021 | UC (76), HC (74) | aYes | Yes |
| Fan et al. | 2019 | UC (41), HC (42) | Yes | No |
| IBD combined | ||||
| Wang et al. | 2023 | IBD (combined; subtype not specified: 37), HC (32) | Yes | No |
| Deng et al. | 2023 | IBD (combined; subtype not specified: 27), HC (29) | No | Yes |
| Goodyear et al. | 2023 | IBD (26 CD | 9 UC), HC (32) | Yes | Yes |
| Kornelsen et al. | 2022 | IBD (CD 35, UC 76), HC (74) | Yes | Yes |
| Prub et al. | 2022 | IBD patients with chronic abdominal pain (32; CD 26 | UC 6), HC (32) | aYes | Yes |
| Thomann et al. | 2021 | IBD patients (31; CD 19 | UC 12), HC (13) | No | Yes |
| Authors . | Year . | Participant groups and sample sizes . | State of disease activity for IBD participants . | |
|---|---|---|---|---|
| Active | Remitted/Inactive | |||
| Crohn’s disease | ||||
| Huang et al. | 2024 | CD active (62), CD remitted (59), HC (91) | Yes | Yes |
| Sun et al. | 2024 | CD with anxiety or depression (33), CD without anxiety or depression (31), HC (29) | No | Yes |
| Thapaliya et al. | 2023 | CD (25), HC (25) | Yes | No |
| Chen et al. | 2023 | CD with pain (24), CD without pain (24), HC (28) | No | Yes |
| Agostini et al. | 2023 | CD active (19), CD remitted (14), HC (18) | Yes | Yes |
| Li et al. | 2022 | CD (20), HC (22) | Yes | aNA |
| Qiu et al. | 2022 | CD (22), HC (22) | Yes | aYes |
| Zhang et al. | 2022 | CD (45), HC (40) | No | Yes |
| Huang et al. | 2022 | CD active (58), CD inactive (57), HC (91) | Yes | Yes |
| Kong et al. | 2022 | CD (34), HC (20) | Yes | Yes |
| Li et al. | 2021 | CD (15), HC (26) | No | Yes |
| Kornelsen et al. | 2020 | CD (35), HC (21) | Yes | Yes |
| Fan et al. | 2020 | CD (42), HC (35) | No | Yes |
| Hou et al. | 2019 | CD (18), HC (18) | No | Yes |
| Bao at al. | 2018 | CD (60), HC (40) | No | Yes |
| Liu et al. | 2018 | CD (43), HC (37) | No | Yes |
| Thomann et al. | 2017 | CD (15), HC (14) | No | Yes |
| Bao et al. | 2016 | CD with pain (25), CD without pain (25), HC (32) | No | Yes |
| Ulcerative colitis | ||||
| Wang et al. | 2022 | UC, IBS, and HC, n = 74 each) | aYes | Yes |
| Kornelsen et al. | 2021 | UC (76), HC (74) | aYes | Yes |
| Fan et al. | 2019 | UC (41), HC (42) | Yes | No |
| IBD combined | ||||
| Wang et al. | 2023 | IBD (combined; subtype not specified: 37), HC (32) | Yes | No |
| Deng et al. | 2023 | IBD (combined; subtype not specified: 27), HC (29) | No | Yes |
| Goodyear et al. | 2023 | IBD (26 CD | 9 UC), HC (32) | Yes | Yes |
| Kornelsen et al. | 2022 | IBD (CD 35, UC 76), HC (74) | Yes | Yes |
| Prub et al. | 2022 | IBD patients with chronic abdominal pain (32; CD 26 | UC 6), HC (32) | aYes | Yes |
| Thomann et al. | 2021 | IBD patients (31; CD 19 | UC 12), HC (13) | No | Yes |
Studies comparing resting-state pre–post intervention are not listed above.
aAssumed inclusion in a sample based on the presentation of means and standard deviations of continuous variables for assessing disease activity.
Abbreviations: CD = Crohn’s disease; HC = healthy controls; UC = ulcerative colitis.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
